Strides Shasun Ltd (STAR.NS) Key Developments | Reuters.com
Edition:
United States

Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Strides Arcolab Ltd receives USFDA approval for Buspirone Hydrochloride Tablets


Tuesday, 26 Aug 2014 04:40am EDT 

Strides Arcolab Ltd:Received approval from the United States Food & Drug Administration (USFDA) for Buspirone Hydrochloride Tablets USP. 

Company Quote

1208.75
 --
11 Jan 2016